Copyright
©The Author(s) 2025.
World J Clin Oncol. Mar 24, 2025; 16(3): 101909
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.101909
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.101909
Ref. | Design, n | ID | Age | Side | Stage | Surgery | Chemotherapy | Radiotherapy | Recurrence | Vital status (months) |
Montag et al[12], 1986 | Retrospective n = 6 | 1 | 22 | Uterine | Unkonwn | Radical hysterectomy and bilateral pelvic lymphadenectomy were performed | VAC | No | No | 156/NED |
2 | 42 | Uterine | Unkonwn | Abdominal hysterectomy, bilateral salpingo-oophorectomy, omental biopsy, and pelvic and paraaortic lymph node biopsies were performed | VAC | No | No | 120/NED | ||
3 | 21 | Uterine | Unkonwn | Radical hysterectomy, bilateral pelvic lymphadenectomy, and incidental appendectomy | VAC (16 course) | Yes | Recurrence 9 months after surgery | 96/NED | ||
4 | 23 | Uterine | Unkonwn | Underwent modified radical hysterectomy, bilateral salpingo-oophorectomy, and bilateral pelvic lymphadenectomy | Doxorubicin | Yes | No | 24/NED | ||
5 | 11 | Cervix | Unkonwn | Underwent radical hysterectomy and bilateral pelvic lymphadenectomy | VAC | No | No | 84/NED | ||
6 | 26 | Cervix | Unkonwn | Underwent radical hysterectomy, bilateral pelvic lymphadenectomy, and paraaortic node sampling | VAC (6 course) | No | No | 17/NED | ||
Ghaemmaghamiet al[13], 2008 | Retrospective n = 6 | 1 | 15 | Vagina | II | Wide local excision | VAC | No | No | 60/NED |
2 | 13 | Vagina | I | Local excision | VAC | No | No | 54/NED | ||
3 | 16 | Vagina | I | Local excision | VAC | No | No | 10/NED | ||
4 | 15 | Cervix | Ⅲ | RH/BOS/LND | Ifosfamide | Yes | Yes | 9/NED | ||
5 | 21 | Cervix | IB2 | Wide local excision/trachelectomy | VAC | No | Yes | 6/NED | ||
6 | 30 | Cervix | IB2 | Conization | VAC | No | No | 8/NED | ||
Kriseman et al[14], 2012 | Retrospective n = 11 | 1 | 17 | Cervix | IB1 | Conization | VAC | No | No | 23/NED |
2 | 12 | Cervix | IB2 | Conization | VAC | No | No | 6/NED | ||
3 | 33 | Cervix | IB1 | TAH and BSO | Cisplatin and doxorubicin | Yes | Yes | Dead of complications related to neutropenic fever | ||
4 | 49 | Cervix | IB1 | TAH and BSO | Cyclophosphamide,doxorubicin,vincristine, and anddacarbazine | Yes | No | Dead of parotid adenocarcinoma | ||
5 | 51 | Cervix | IB2 | Conization | No | No | No | 19/NED | ||
6 | 2 | Cervix | IIA | Polypectomy | VAC | No | No | 35/NED | ||
7 | 12 | Uterine | IB2 | TAH | VAC | No | No | 121/NED | ||
8 | 17 | Cervix | Unkonwn | Conization | Vincristine,doxorubicin, and cyclophosphamide | No | No | Dead of disease | ||
9 | 34 | Cervix | Unkonwn | Conization | VAC, FAC | No | Unkonwn | Dead of unknown cause | ||
10 | 27 | Cervix | IB2 | Conization | No | No | Unkonwn | Alive with disease | ||
11 | 18 | Cervix | IB1 | Conization | VAC | No | No | 4/NED | ||
Narin et al[15], 2016 | Retrospective n = 5 | 1 | 16 | Cervix | I | Polypectomy | VAC | No | No | 102/NED |
2 | 11 | Cervix | I | Polypectomy | VAC | No | Yes | 57/NED | ||
3 | 23 | Cervix | I | Radical hysterectomy | VAC + cisplatin | Yes | Yes | 22/NED | ||
4 | 14 | Cervix | I | Polypectomy | VAC | No | No | 37/NED | ||
5 | 15 | Cervix | I | Polypectomy | VAC | No | No | 15/NED |
Ref. | Design, n | Age | Side | Stage | Surgery | Chemotherapy | Radiotherapy | Recurrence | Vital status (months) |
Gruessner et al[16], 2004 | Case report | 5 | Cervix | IA | Polypectomy | VAC | No | No | 39/NED |
Scaravilli et al[17], 2009 | Case report | 35 | Cervix | I1 | Total laparohysterectomy with bilateral annessiectomy and pelvic lymphadenectomy | Cysplatinum, adriamycin and dacarbazin + vincristine and actinomycin | No | No | 12+/NED |
Koukourakis et al[18], 2009 | Case report | 20 | Cervix | IIA | Radical hysterectomy, upper vaginectomy and bilateral pelvic lymphadenectomy were performed | Ifosfamide + etoposide + cisplatin | Yes | No | 3/NED |
Ocheke et al[19], 2011 | Case report | 16 | Cervix | Unkonwn | Polypectomy | No | No | Yes | 6/Died |
Karaman et al[20], 2011 | Case report | 22 | Cervix | IA | Conization | VAC | No | No | 18/NED |
Melo et al[21], 2012 | Case report | 20 | Cervix | IA | Radical surgery | Ifosfamide vincristine actinomycin | No | No | 36/NED |
Xu et al[22], 2022 | Case report | 39 | Cervix | IB3 | Laparoscopic radical hysterectomy, bilateral salpingo-oophrectomy and pelvic lymph node dissection | VAC | No | No | 49/NED |
Pop et al[7], 2023 | Case report | 46 | Cervix | IA1 | C1-type hysterectomy | vincristine ifosfamide doxorubicin etoposide and CHT | Yes | Yes | 60/NED |
- Citation: Ma HR, Zhang D, Li L, Qi L, Wang L, Li YT, Wang YR. Targeted maintenance therapy for a young woman with cervical rhabdomyosarcoma: A case report and review of literature. World J Clin Oncol 2025; 16(3): 101909
- URL: https://www.wjgnet.com/2218-4333/full/v16/i3/101909.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i3.101909